Insiders Updates
Investing in Intellia Therapeutics Inc (NTLA): What You Must Know
Intellia Therapeutics Inc’s recent filing unveils that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
Menu
Intellia Therapeutics Inc’s recent filing unveils that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
Intellia Therapeutics Inc’s recently made public that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
Intellia Therapeutics Inc’s recently made public that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
In a filing, Intellia Therapeutics Inc revealed its EVP, Chief Financial Officer Dulac Edward J III unloaded Company’s shares for